Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.41
+0.45 (3.22%)
Aug 14, 2025, 2:04 PM - Market open
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $585.27 million as of August 14, 2025. Its market cap has decreased by -69.00% in one year.
Market Cap
585.27M
Enterprise Value
-105.27M
1-Year Change
-69.00%
Ranking
Category
Stock Price
$14.41
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $585.27M, an increase of 51.89%. That is a compound annual growth rate of 8.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 556.84M | -13.16% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 594.99B |
| Johnson & Johnson | 417.92B |
| AbbVie | 357.75B |
| UnitedHealth Group | 243.60B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.73B |